Mukherjee, Manali
Kjarsgaard, Melanie
Radford, Katherine
Huang, Chynna
Leigh, Richard
Dorscheid, Delbert R.
Lemiere, Catherine
Boulet, Louis-Philippe
Waserman, Susan
Martin, James
Nair, Parameswaran http://orcid.org/0000-0002-1041-9492
Clinical trials referenced in this document:
Documents that mention this clinical trial
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
https://doi.org/10.1186/s13223-019-0337-2
Funding for this research was provided by:
AllerGen (Canadian Severe Asthma Clinical Trials Consortium)
Novartis Pharmaceuticals Canada (Investigator-initiated)
Article History
Received: 9 November 2018
Accepted: 28 March 2019
First Online: 3 April 2019